Pubblicazioni

Neoadjuvant Therapy for Rectal Cancer: Updates From the UNICANCER-PRODIGE 23 Trial

2022 - CLINICAL COLORECTAL CANCER

Intensified Total Neoadjuvant Therapy Versus Intensified Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: A Propensity Score Matching Analysis

2022 - ANTICANCER RESEARCH
DE Felice, Francesca; Musio, Daniela; Iafrate, Franco; Caponnetto, Salvatore; Picone, Vincenzo; D'Ambrosio, Giancarlo; Magliocca, Fabio Massimo; Tozzi, Francesca; DE Toma, Giorgio; Tombolini, Vincenzo; Cortesi, Enrico

S-Adenosylmethionine Supplementation May Reduce Cancer-Related Fatigue: A Prospective Evaluation Using the FACIT-F Questionnaire in Colon Cancer Patients Undergoing Oxaliplatin-Based Chemotherapy Regimens

2021 - CHEMOTHERAPY
Onorato, A.; Napolitano, A.; Spoto, S.; Incorvaia, L.; Russo, A.; Santini, D.; Tonini, G.; Vincenzi, B.

Tolerability of oxaliplatin-based neoadjuvant chemoradiotherapy in elderly locally advanced rectal cancer patients: a case-control study of a real-life experience

2019 - ANTICANCER RESEARCH
De Felice, F.; Siniscalchi, B.; Bulzonetti, N.; Caiazzo, R.; Musio, D.; Tombolini, V.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma